ABSTRACT

To date there is no established tumor marker for the clinical follow-up of glioblastoma, WHO grade IV, (GBM) which constitutes the most frequent and malignant primary brain tumor. However, since there is promising data that the serum glial fibrillary acidic protein (sGFAP) may serve as a biomarker for glial brain tumors, this prospective study aimed at evaluating the diagnostic relevance of perioperative changes in sGFAP levels for the assessment of residual glial tumor tissue in patients undergoing surgery of intracerebral tumors.

Journal of Neuro-Oncology, 139(3), 541–546

Somatic Mutations in Solid Tumors: A Spectrum at the Service of Diagnostic Armamentarium or an Indecipherable Puzzle? The Morphological Eyes Looking for BRAF and Somatic Molecular Detections on Cyto-Histological Samples

Pre- and early postoperative GFAP serum levels in glioma and brain metastases

ABSTRACT

Autres Publications

Somatic Mutations in Solid Tumors: A Spectrum at the Service of Diagnostic Armamentarium or an Indecipherable Puzzle? The Morphological Eyes Looking for BRAF and Somatic Molecular Detections on Cyto-Histological Samples

Hair Ethyl Glucuronide Concentrations in Teetotalers: Should We Re-Evaluate the Lower Cut-Off?

Livestock-Associated Meticillin-Resistant Staphylococcus Aureus (MRSA) among Human MRSA Isolates, European Union/European Economic Area Countries, 2013